It is clear that the main cellular mission of the molecular motor kinesin-5 (known as Eg5 in vertebrates) is to cross-link antiparallel microtubules and to slide them apart, thus playing a critical role during bipolar spindle formation. Nonetheless, important questions about the cell biological and biophysical mechanisms of Eg5 remain unanswered. With the 20th 'birthday' of Eg5 approaching, we discuss recent insights into the in vitro and in vivo functions of Eg5, in the context of our own recent work.
Introduction
To ensure the accurate segregation of chromosomes in eukaryotes, the mitotic spindle must dynamically assemble and disassemble, correctly and at appropriate times [1] [2] [3] [4] . The concerted actions of a number of proteins, molecular motors as well as microtubule-associated proteins, are necessary to effect centrosome separation, chromosome alignment, chromatid segregation and spindle elongation [1, 5] . Of these proteins, the molecular motor kinesin-5 (known as Eg5 in vertebrates) is absolutely required for the dynamic assembly and function of the mitotic and meiotic spindles [6] [7] [8] . It is almost two decades since proteins of this family were first described (BimC4 [9] , Cut7 [10] ). In the interim, the functions and mechanisms of Eg5 have been intensively investigated.
Eg5 function is tightly controlled by CyclinB-Cdk1 (cyclin-dependent kinase 1)-mediated phosphorylation, which occurs at the outset of mitosis and controls the localization of Eg5 to microtubules [11] [12] [13] . Eg5 cross-links microtubules into bundles containing both parallel-and antiparallel-overlapped microtubules, but with a strong preference for antiparallel overlaps [14] . Cross-linking is possible because the homotetrameric structure of the Eg5 motor provides a pair of motor domains at each end of the molecule [15, 16] (Figure 1 ). The Eg5 mechanism, like that of other molecular motors, transduces the chemical energy of ATP to perform directed mechanical work on microtubules. The plus-end-directed stepping activity of Eg5 [17] slides antiparallel microtubules away from each other, as seen in centrosome separation and/or anaphase spindle elongation. This key function of sliding antiparallel microtubules apart has been demonstrated successfully in vitro [18] .
In order to better understand the molecular mechanism of Eg5, dimeric and monomeric constructs of Eg5 have been examined intensively in biochemical [19] [20] [21] , structural [22] [23] [24] and mechanical [25] [26] [27] experiments. Interestingly, despite similarities to kinesin-1 in its primary and crystal structures, Eg5 shows considerably slower kinetics/motility and very much lower processivity. The molecular details determining processivity remain to be elucidated.
The discovery of an Eg5-specific small inhibitor, monastrol [28] , stimulated a widespread (and ongoing) search for chemical inhibitors of mitotic molecular motors. Most Eg5 inhibitors reported to date are non-competitive and bind to a specific site on the motor domain, trapping the motor in an ADP state that has a weak but non-zero affinity for microtubules [29] . In the presence of an Eg5 inhibitor, Eg5 therefore cannot separate centrosomes and cannot maintain spindle structure. As a result, the cell cycle is arrested at mitotic onset, with accompanying formation of a monastrol microtubule structure. Eg5 inhibitors have proved to be important tools for investigating the function of the motor in vitro and in vivo. Some are currently undergoing clinical trials as novel anti-cancer therapeutics [30] .
In vitro observations: diffuse, hop or walk functions
It has been shown in an optical trapping single-molecule assay that dimeric Eg5 molecules move along microtubules processively [25] . Eg5 tetramers have also been seen to move processively along single microtubules [31] . However, the processivity (approx. eight steps) is very much lower than that of kinesin-1 (>100 steps). It is most likely that Eg5 works in large teams inside cells [32] . This raises the question: why are single Eg5 molecules processive? We recently revisited this question by engineering a single-headed Eg5 heterodimer and analysing its performance using a conventional multiplemolecule microtubule sliding motility assay, which gives the motors and their microtubule tracks a similar geometry to the in vivo spindle situation. If Eg5 requires the use of a kinesin-1-like co-ordinated alternating-heads walking mechanism, then our single-headed motor should show slower motility than wild-type double-headed Eg5 [33] . In the event, we found that our engineered single-headed Eg5 molecule finds the antiparallel overlap zone, it could start sliding the microtubules apart using the processive walking mode, although it would fail to do so in most cases (Stage 3, see the text for details). Once a team of Eg5 molecules arrives, they would then be able to efficiently slide apart the antiparallel overlapping microtubules using the hopping mode (Stage 4a). In the situation where an extensive force is applied to the antiparallel microtubules (for example, as a consequence of cortical dynein pulling on the astral microtubules; Stage 4b), the brake mode of Eg5 molecules would resist this force, giving rise to a balance of force.
moves microtubules as fast as a double-headed control Eg5 [26] . This result indicates that the second motor domain is not essential for force generation, which in turn indicates that Eg5 can make force by a non-processive hopping mechanism. The result is consistent with the biochemical observations [34] , but not with single-molecule mechanical data [25] . Below, we discuss possible explanations for this discrepancy.
First, the discrepancy could have come from differences in experimental geometry. Processivity is the result of a race between the two heads. If the trailing head detaches from the microtubule before the tethered head binds to its next binding site, the motor will detach and diffuse away from the track. If, on the other hand, the leading head succeeds in binding before the trailing head has detached, the motor will take a processive step. In a single-bead optical trapping assay, a single Eg5 molecule is held close to the microtubule, and this could, in principle, increase the landing rate. If processive events occur, an increased landing rate will increase the frequency of processive events. A second possibility is that processivity increases under load. The backwards force acting on the microtubule-bound head imparts strain, and this might easily reduce the detachment rate constant for the load-bearing head, while having little influence on the binding rate of the tethered head. This would make the motor more processive. In a gliding assay where Eg5 molecules are not exposed to external load, they would then behave as non-processive motors, whereas in the optical trap, they will show some processivity. A third possibility is that dimeric Eg5 molecules move processively by a hopping mechanism, instead of a kinesin-1-like alternate-heads walking mechanism. In this model, the Eg5 molecule would use its second head as a sliding tether, as has been proposed for the K-loop of KIF1A [35] and for the tail domain of kinesin-14 [36] . In this kind of mechanism, the second Eg5 head would be essential for processive movement, but not for non-processive movement. A fourth possible model would be that, although Eg5 can, in principle, make short processive runs, these are relatively rare, so that most Eg5 landing events only result in a single step. These few processive events would be the only events detected in single-molecule assays [25, 31] , because the optical trapping technique misses non-processive events in the thermal noise. This explanation would be consistent with a biochemical report that shows the detachment rate of Eg5 from microtubules in its one-head binding state is >10-fold higher than the binding of the second motor domain to microtubules [37] . In our current working model, Eg5 uses, most of the time, only one of its two heads as a force generator, especially when it works in a team, as in a multiple-motor gliding assay or in spindle microtubules. Thus the second motor domain seems to be dispensable for driving microtubule sliding at low loads, a situation that is potentially relevant to that in cells, or especially when working together in cells. Why, then, does Eg5 make homodimers? Obviously, two heads increases the probability of attachment of the motor to the microtubule. Two heads are clearly also required even for short bursts of processivity [25] . Or it could simply be necessary first to form coiled-coil homodimers in order to then form tetramers that can cross-link antiparallel microtubules. Whether there are other reasons for two-headedness remains to be seen.
It is interesting and important to note that Eg5 can operate in a diffusive mode, in which the homoheteromer executes a one-dimensional random diffusional scan along the microtubule. This diffusional mode was originally reported in the presence of Eg5 inhibitor [38] , but it turned out that it can also occur at physiological ionic strength and that the motor changes from a diffusive to a directional mode upon binding to the second microtubule [39] . Thus current evidence indicates that Eg5 can switch between hopping, walking and diffusing modes, depending on the cellular circumstances.
In vitro observations: braking function
In addition to hopping, walking and diffusing modes, Eg5 shows a brake function. We have shown previously that, when mixed with kinesin-1, dimeric Eg5 molecules drastically slow down microtubule sliding driven by the faster motor, but that this drag-brake effect is relieved in the presence of a small-molecule Eg5 inhibitor, monastrol [29] . This is because monastrol drives Eg5 to change its mode from a high-friction (braking) mode to a low-friction (diffusive) mode. The brake function of Drosophila Eg5 homologue, KLP61F, has been studied in vitro using tug-of-war microtubule sliding assays that pit the kinesin-5 against a minus-end-directed kinesin-14 (Ncd [40] ). Eg5 is reported to act as a brake on dynein-driven spindle elongation in anaphase in vivo in Caenorhabditis elegans [41] and in Dictyostelium [42] . In neurons, Eg5 knockdown leads to longer and more branched axons as a result of release of this brake [43] .
These accumulating data raise a question: what is the relationship between the two functions of Eg5, as a motor that drives microtubule sliding and as a brake that resists microtubule sliding? Eg5 molecules, like other molecular motors, go through different nucleotide states, motor · ATP, motor · ADP∼P i , motor · ADP and back to motor alone. Among these, only the motor · ADP state shows weak binding to microtubules (the molecule is trapped in this state in the presence of Eg5 inhibitors, thus showing a low-friction mode), whereas the others are strong binding. To generate either power or drag, the motor must have traction and so must be strong-binding. In order to understand the relationship between the weak and strong states, we have investigated a mutant Eg5 (K. Kaseda, K. Hirose, A.D. McAinsh and R.A. Cross, unpublished work). When basic residues in loop 11, a possible microtubule-binding site, are mutated, Eg5 homodimer shows lower affinity for microtubules, with correspondingly less braking action on kinesin-1 molecules in a tugof-war assay. Surprisingly, this mutant moves microtubules ∼50% faster than wild-type Eg5 molecules. This suggests that part of the strong-binding time corresponding to the braking function is lacking in the mutant, resulting in faster dissociation from microtubules and faster motility. In contrast, neck-linker mutants tend to stay longer in a strong binding state, and, as a result, show higher affinity for microtubules, show correspondingly more drag and are slower. Collectively, these results indicate that the power stroke and drag (braking) stroke are closely related to each other in the strong-binding state and that fine-tuning of the ratio of these two functions defines the overall properties of the motor. In cells, one of the two functions would be dominant depending on the situation, e.g., when a faster motor such as dynein works at the same time, the brake function becomes dominant, whereas at lower velocities, the motor function dominates.
In vivo observations: bipolar spindle formation
Using molecular tools such as RNA interference, smallmolecule inhibitors and antibodies, as well as loss-of-function mutagenesis, it has been established that Eg5 is critically involved in bipolar spindle formation [17, [44] [45] [46] [47] [48] [49] [50] . It has been shown using live-cell imaging that Eg5 plays a critical role in separating centrosomes in prophase [51] . In our recent study of high-resolution live imaging of human HeLa cells, not only did we confirm the previous observations, but also we observed that the importance of Eg5 becomes reduced as mitosis progresses (K. Kaseda, A.D. McAinsh and R.A. Cross, unpublished work). When Eg5 is partially inhibited by a small-molecule inhibitor, centrosomes hardly move, causing almost the entire cell population to follow the so-called 'prometaphase pathway' [52] , in which nuclear envelope breakdown occurs with both incipient spindle poles remaining on the same side of the chromatin. In this condition of partial inhibition, these cells eventually form bipolar spindles, but do so extremely slowly compared with control cells. The metaphase bipolar spindles are less stable in the presence of the limited concentration of inhibitor and they occasionally collapse. However, the metaphase spindle length (when stable) and the rate of spindle elongation in anaphase are not affected by partial inhibition of Eg5 (K. Kaseda, A.D. McAinsh and R.A. Cross, unpublished work), although Eg5 does localize along spindle microtubules towards the end of anaphase. Thus it seems that the importance of Eg5 becomes less as cells proceed through mitosis. It will be important to determine the regulatory mechanisms that govern this dynamic requirement for Eg5 throughout mitosis.
The role of Eg5 in these component processes also varies from one organism to another. For example, although Eg5 is essential in human cells for centrosomes to separate to opposite side of the condensed chromatin [11, 51] , it is not essential for this process in Drosophila embryos [53] . Eg5 determines metaphase spindle length in yeast [46, 47] and Drosophila embryos [54] , but not in Drosophila S2 cells [55] . Eg5 drives anaphase pole separation in yeast [47] and Drosophila embryos [54] , but not in C. elegans [41] , Dictyostelium [42] or mammalian cells [56] . Eg5 plays a role in generating microtubule poleward flux in Xenopus egg extract [57] and Drosophila embryos [54] , but not in mammalian cells [56] . It is not yet understood why there are such differences. The differing role of Eg5 could be determined by the differing organization of microtubules within the mitotic spindle in different organisms. Alternatively, different spindles might contain differing motor activities that can compensate for Eg5 activity. For example, in Drosophila S2 cells, overexpression of Eg5 (KLP61F) does not affect spindle length possibly because of the coupling of microtubule sliding to minus-end depolymerization. In contrast, overexpression of Eg5 in budding yeast (Cin8 [46] ) does increase spindle length, perhaps due to the lack of a minus-end depolymerization activity (kinesin-13s) in yeast.
Linking biophysics to cell biology: a model
In vitro observations show that Eg5 can diffuse, hop, walk and brake. How does Eg5 use these modes? Our view is that current data support a conceptual model in which all these different modes of Eg5 are harnessed, and perhaps regulated, during the dynamic assembly of the bipolar mitotic spindle (Figure 1 ). In this model, the main function of Eg5 is to cross-link and slide antiparallel microtubules in mitosis. This activity separates the centrosomes and, in some cases, is required to maintain bipolar spindle structure in prometaphase/metaphase, as well as driving separation of the spindle poles during anaphase. Upon cyclinB-Cdk1-dependent phosphorylation, Eg5 molecules are recruited to microtubules. In order to localize efficiently to regions of overlap between antiparallel microtubules, the diffusional mode of the motor would be used, because this mode does not require activation of the Eg5 ATPase [39] . Recent evidence indicates that the non-motor C-terminal tails of Eg5 may contribute to the preferential cross-linking of these antiparallel microtubules. As soon as a single Eg5 molecule finds the antiparallel overlap zone, it would begin to slide the microtubules apart using its hopping mode (non-processive) and potentially also the processive mode, which may be advantageous in this situation [25, 31] . Over time, further Eg5 molecules are recruited, resulting in a team of motors which would generate a more stable, steady, sliding force. When encountering rapid or opposite movement of antiparallel microtubules by other molecules such as dynein [41, 42] or kinesin-14 [54] , the Eg5 brake mode could then give rise to force balance within the spindle. At the same time, Eg5 molecules which encounter parallel microtubules would also cross-link them, but, in this case, the motors would stabilize the microtubule bundle (by a mechanism similar to that observed for kinesin-14s [58, 59] ). To test this 'multi-mode' model of Eg5 action, we will need to generate specific mutants that alter or disable these different modes in vitro. Only by reintroducing these in vitro engineered mutants of Eg5 into cells will we be able to determine how the walking, hopping, diffusing and braking modes of kinesin-5 drive spindle dynamics during mitosis and meiosis. 
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